June 2, 2025
BURLINGTON, Ontario – May 30, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated May 10, 2025, it has entered into debt settlement agreements with certain of its creditors (the “Creditors”) to issue...
May 27, 2025
BURLINGTON, Ontario – May 27, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $3,000,000 of gross proceeds, consisting of up to 13,636,364 units (the...
May 26, 2025
BURLINGTON, ON – May 26, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar...
May 15, 2025
The evolution of dental anesthesia is entering a new era with the introduction of LQS, Lidocaine QuickStrip™, a cutting-edge muco-adhesive oral thin film developed by Rapid Dose Therapeutics (RDT; CSE: DOSE) in partnership with Skycare Compounding Labs. Utilizing proprietary QuickStrip™ technology, LQS bridges the gap...
May 9, 2025
BURLINGTON, Ontario – May 09, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that it has agreed with certain of its creditors (the “Creditors”) to issue up to an aggregate of 2,500,000 common shares (the “Settlement Shares”) to such Creditors...
April 8, 2025
BURLINGTON, Ontario – April 8, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce an update to the ongoing collaboration project with the...
April 3, 2025
BURLINGTON, Ontario – April 3, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce its participation at major dental tradeshows across Canada to...
April 1, 2025
BURLINGTON, Ontario – April 1, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its private placement financing (the “Financing”), and consistent with prior quarters, the Company...
February 18, 2025
BURLINGTON, Ontario – February 18, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $5,000,000 of gross proceeds, consisting of up to 20,833,333 common shares...
January 28, 2025
BURLINGTON, ON – January 28, 2025 – Rapid Dose Therapeutics Corp. (RDT) (CSE: DOSE), a Canadian biotechnology company working with an international company in oral nicotine products, is pleased to announce the expansion of their collaboration through the continuation of the exclusive pre-commercialization agreement. This...